Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset NHI
Coverage 178,384 Raw stories ingested 24,013 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 53s ago
  • FMP Forex News Fetch every 5 min 1m ago
  • CoinGecko News Fetch every 5 min 1m ago
  • FIO Stock News Fetch every 10 min 4m ago
  • Patria Stock News Fetch every 10 min 4m ago
  • Editorial rewrite Rewrite every minute 53s ago
  • Asset sync Assets every 1 hour 4m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Clear
Details Date Content Source Relevance
2026-09-01 14:15 15d ago
2026-09-01 04:03 15d ago
Canada Pension Plan Investment Board získala podíl v NHI
NHI National Health Investors
FMP Stock News 78
Original source text
Canada Pension Plan Investment Board bought a new position in shares of National Health Investors, Inc. (NYSE:NHI – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 16,100 shares of the real estate investment trust’s stock, valued at approximately $1,228,000.

Several other hedge funds and other institutional investors have also bought and sold shares of NHI. International Assets Investment Management LLC bought a new stake in National Health Investors during the fourth quarter valued at $27,000. EverSource Wealth Advisors LLC raised its position in shares of National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new position in shares of National Health Investors in the 4th quarter worth about $33,000. Allworth Financial LP acquired a new position in shares of National Health Investors in the 2nd quarter valued at about $42,000. Finally, Advisory Services Network LLC acquired a new position in shares of National Health Investors in the 3rd quarter valued at about $65,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

Analyst Ratings Changes NHI has been the subject of several recent analyst reports. Truist Financial decreased their target price on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Deutsche Bank Aktiengesellschaft dropped their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. BMO Capital Markets cut their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Wells Fargo & Company reduced their price objective on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Finally, Zacks Research lowered shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, National Health Investors currently has a consensus rating of “Moderate Buy” and an average target price of $83.86.

Check Out Our Latest Analysis on National Health Investors National Health Investors Price Performance Shares of NYSE NHI opened at $71.26 on Tuesday. National Health Investors, Inc. has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The stock has a market cap of $3.50 billion, a price-to-earnings ratio of 20.60, a PEG ratio of 3.83 and a beta of 0.51. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The firm’s 50-day simple moving average is $75.69 and its 200 day simple moving average is $78.61.

National Health Investors (NYSE:NHI – Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The firm had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The business’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts anticipate that National Health Investors, Inc. will post 4.78 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.2%. National Health Investors’s dividend payout ratio is 106.36%.

Insider Buying and Selling at National Health Investors In related news, Director Robert A. Mccabe, Jr. purchased 890 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This represents a 2.06% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at $9,177,473.44. The trade was a 1.14% increase in their position. The SEC filing for this purchase provides additional information. Corporate insiders own 2.70% of the company’s stock.

(Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Further Reading Five stocks we like better than National Health Investors Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season Insiders Are Betting Big on These 3 Healthcare Stocks 3 Stocks for Investors Who Still Believe Cash Is King Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
2026-08-24 14:40 23d ago
2026-08-24 04:07 23d ago
BlackRock získal podíl v National Health Investors
NHI National Health Investors
FMP Stock News 78
Original source text
BlackRock Inc. bought a new position in shares of National Health Investors, Inc. (NYSE:NHI – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 8,733,237 shares of the real estate investment trust’s stock, valued at approximately $665,997,000. BlackRock Inc. owned 18.02% of National Health Investors as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. International Assets Investment Management LLC bought a new position in shares of National Health Investors during the 4th quarter valued at about $27,000. EverSource Wealth Advisors LLC raised its holdings in shares of National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in National Health Investors during the fourth quarter worth approximately $33,000. Advisory Services Network LLC bought a new stake in National Health Investors during the third quarter worth approximately $65,000. Finally, Triumph Capital Management acquired a new position in National Health Investors in the third quarter worth approximately $66,000. 62.51% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets Several research analysts have issued reports on NHI shares. BMO Capital Markets dropped their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Zacks Research cut National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Wells Fargo & Company cut their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Monday, June 1st. Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Thursday, June 25th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $83.86.

Check Out Our Latest Research Report on National Health Investors Insider Transactions at National Health Investors In related news, CEO D. Eric Mendelsohn purchased 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert A. Mccabe, Jr. purchased 890 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average price of $71.65 per share, with a total value of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 2.70% of the company’s stock.

National Health Investors Trading Up 0.3% National Health Investors stock opened at $73.59 on Monday. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The firm has a market capitalization of $3.61 billion, a price-to-earnings ratio of 21.27, a P/E/G ratio of 3.36 and a beta of 0.51. The company has a 50 day moving average price of $75.48 and a 200 day moving average price of $79.09.

National Health Investors (NYSE:NHI – Get Free Report) last released its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The company had revenue of $121.32 million during the quarter. During the same quarter in the previous year, the company earned $1.22 EPS. National Health Investors’s revenue for the quarter was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Research analysts forecast that National Health Investors, Inc. will post 4.78 EPS for the current year.

National Health Investors Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.0%. National Health Investors’s dividend payout ratio (DPR) is presently 108.67%.

National Health Investors Company Profile (Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Featured Articles Five stocks we like better than National Health Investors VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? 3 Closed-End Funds to Maximize Dividend Payments Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy? $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI – Free Report).

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
2026-08-12 12:50 1mo ago
2026-08-12 08:00 1mo ago
National Health Investors blízko minima, dividendový výnos 5,3 %
NHI National Health Investors
FMP Stock News 72
Original source text
HomeDividends AnalysisREITs AnalysisReal Estate Analysis

SummaryNational Health Investors, Inc. is a REIT trading near 52-week lows, offering a 5.3% yield and a forward P/FFO of 14.5.NHI is rapidly expanding its SHOP platform, targeting 40-50% portfolio exposure within 3 years, aiming for higher revenue and profit growth.Recent FFO softness reflects deliberate investments in SHOP infrastructure, with management guiding for 8-9% SHOP NOI growth in H2 and moderating G&A expense growth.I maintain a Buy rating on NHI, citing discounted valuation, strong balance sheet, and a well-covered, rising dividend supporting a compelling total return outlook.Looking for a portfolio of ideas like this one? Members of iREIT®+HOYA Capital get exclusive access to our subscriber-only portfolios. Learn More » z1b/iStock via Getty Images

Earnings season can be a great time to pick up bargains due to knee-jerk market reactions. This can especially be the case when the long-term investment thesis isn’t broken. Such I find the case with National Health

23.48K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of NHI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I am not an investment advisor. This article is for informational purposes and does not constitute as financial advice. Readers are encouraged and expected to perform due diligence and draw their own conclusions prior to making any investment decisions.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-08-11 00:44 1mo ago
2026-08-10 18:56 1mo ago
National Health Investors zklamal ve FFO, tržby překonaly odhady
NHI National Health Investors
FMP Stock News 72
Original source text
National Health Investors (NHI - Free Report) came out with quarterly funds from operations (FFO) of $1.19 per share, missing the Zacks Consensus Estimate of $1.26 per share. This compares to FFO of $1.22 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an FFO surprise of -5.56%. A quarter ago, it was expected that this health care real estate investment trust would post FFO of $1.21 per share when it actually produced FFO of $1.24, delivering a surprise of +2.48%.

Over the last four quarters, the company has surpassed consensus FFO estimates two times.

National Health Investors, which belongs to the Zacks REIT and Equity Trust - Other industry, posted revenues of $121.32 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 2.81%. This compares to year-ago revenues of $90.66 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future FFO expectations will mostly depend on management's commentary on the earnings call.

National Health Investors shares have lost about 1.4% since the beginning of the year versus the S&P 500's gain of 13.3%.

What's Next for National Health Investors?While National Health Investors has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's FFO outlook. Not only does this include current consensus FFO expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of estimate revisions.

Ahead of this earnings release, the estimate revisions trend for National Health Investors was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus FFO estimate is $1.15 on $112.94 million in revenues for the coming quarter and $4.87 on $459.2 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, REIT and Equity Trust - Other is currently in the top 33% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Creative Media & Community Trust (CMCT - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026.

This real estate investment trust is expected to post quarterly loss of $0.51 per share in its upcoming report, which represents a year-over-year change of +100%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Creative Media & Community Trust's revenues are expected to be $28.1 million, down 5.4% from the year-ago quarter.
2026-08-10 22:20 1mo ago
2026-08-10 16:05 1mo ago
NHI zvýšila EPS a dokončila prodej portfolia NHC
NHI National Health Investors
FMP Stock News 92
Original source text
, /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) announced today its results for the quarter ended June 30, 2026.

CEO Comments

"We continued to expand our Senior Housing Operating Portfolio ("SHOP") with second quarter invested capital of $854.8 million, a 137% increase from the prior year period," said Eric Mendelsohn, NHI's President and CEO. "Our total SHOP NOI for the second quarter increased by approximately 188% year-over-year driven by our recent acquisitions while the same-store SHOP results were ahead of expectations."

"We also completed the sale of the NHC portfolio, one of the largest transactions in the Company's history, reducing balance sheet leverage to well below our target range and providing significant financial flexibility to pursue additional private-pay senior housing investments. In addition, we recently appointed a Chief Operating Officer to further strengthen our asset management and business development capabilities as we navigate the current operating environment and position the Company to capitalize on the long-term demographic tailwinds supporting our industry. With a strengthened balance sheet, substantial liquidity, and a growing SHOP portfolio, we believe NHI is well positioned to execute on attractive investment opportunities and create long-term value for stockholders," concluded Mr. Mendelsohn.

Second Quarter Highlights

Net income attributable to common stockholders per diluted share for the quarter ended June 30, 2026 increased 45.6% to $1.15 per share compared to $0.79 per share for the same period in the prior year. Net income attributable to common stockholders per diluted share for the six months ended June 30, 2026 increased 28.7% to $1.97 per share compared to $1.53 per share for the same period in the prior year. Net income attributable to common stockholders for the three and six months ended June 30, 2026 included gains on dispositions of real estate properties of $22.0 million and $24.6 million, respectively. In the six months ended June 30, 2026, the Company disposed of five real estate properties in the Real Estate Investments segment for aggregate net proceeds of $98.5 million. The Company did not have any dispositions of real estate properties in the prior year period. National Association of Real Estate Investment Trusts ("NAREIT") Funds from Operations ("FFO") per diluted share for each of the quarters ended June 30, 2026 and 2025 was $1.19 per share. NAREIT FFO per diluted share for the six months ended June 30, 2026 increased 3.4% to $2.42 per share compared to $2.34 per share for the same period in the prior year. NAREIT FFO for the three and six months ended June 30, 2025 included proxy contest and related expenses of $1.3 million and $1.6 million, respectively, related to the Company's response to a proxy campaign associated with the Company's 2025 annual stockholders meeting. Additionally, NAREIT FFO for the six months ended June 30, 2025 included $1.2 million of transaction costs related to an acquisition in the SHOP segment that did not materialize. Normalized FFO per diluted share for the quarter ended June 30, 2026 decreased 2.5% to $1.19 per share compared to $1.22 per share for the same period in the prior year. Normalized FFO per diluted share for the six months ended June 30, 2026 increased 2.1% to $2.42 per share compared to $2.37 per share for the same period in the prior year. Normalized FFO for the three and six months ended June 30, 2025 included $1.5 million and $1.9 million, respectively, of gains from an equity method investment. Both the quarter and six months ended June 30, 2026 included $1.1 million of compensation costs related to the CFO transition and $0.7 million of deferred income tax expense. Normalized FFO for the six months ended June 30, 2025 included the transaction costs described above. Normalized Funds Available for Distribution ("FAD") for the quarter ended June 30, 2026 increased $5.7 million to $61.6 million compared to $56.0 million for the same period in the prior year. Normalized FAD for the six months ended June 30, 2026 increased $12.1 million to $124.1 million compared to $112.0 million for the same period in the prior year. These increases primarily resulted from the net impact of the Company's acquisitions activity. In addition, the Company had $0.5 million in compensation costs in the quarter and six months ended June 30, 2026 related to the CFO transition. Quarterly Financial Results

Results for the quarter ended June 30, 2026 compared to the same period in the prior year were impacted by the following:

Rental income increased $1.1 million, or 1.6%, which primarily included a $3.0 million increase from 11 properties acquired since April 1, 2025, partially offset by a $1.9 million decrease from seven properties transitioned to the SHOP segment in August 2025. Resident fees and services, less senior housing operating expenses, increased $7.2 million which included a $4.7 million increase from acquisitions of 20 properties since April 1, 2025 and a $2.7 million increase from the seven transitioned properties discussed above. On a same store ("Same Store") basis, resident fees and services, less senior housing operating expenses, declined $0.2 million. Interest income from mortgage and other notes receivable decreased $1.0 million, or 16.1%, primarily due to a net reduction in the principal amounts of mortgage and other notes receivable outstanding in the current period compared to the prior year period. Depreciation and amortization increased $5.6 million, or 28.3%, primarily due to a $5.4 million increase from acquisitions activity since April 1, 2025. Interest expense increased $0.8 million, or 5.4%, primarily due to a $4.7 million increase from the 2033 Senior Notes issued in September 2025, partially offset by repayments of the bank term loan and a private placement note and also partially offset by the impact of lower interest rates on the Company's variable rate debt. Legal expense decreased $0.7 million, or 59.4%, primarily due to costs incurred in the prior year period related to the transitioning of seven properties into the SHOP segment in August 2025. General and administrative expenses increased $2.7 million, or 44.0%, primarily due to higher compensation costs and costs incurred in the current period related to the Company's CFO transition. Proxy contest and related expenses of $1.3 million for the quarter ended June 30, 2025 consisted of proxy advisory costs related to the response to a proxy campaign associated with the Company's 2025 annual meeting of stockholders. Loan and realty gains, net, of $1.4 million for the quarter ended June 30, 2025 included a $1.8 million reduction in the Company's credit loss reserves as a result of a non-performing loan repayment received in the period. Gains on dispositions of real estate properties of $22.0 million for the quarter ended June 30, 2026 primarily related to the sale of four properties in the Real Estate Investments segment. Gains from equity method investment of $1.5 million for the quarter ended June 30, 2025 related to cash distributions received from this investment. Income tax expense of $0.7 million for the quarter ended June 30, 2026 consisted of deferred income tax expense primarily resulting from the changes in the operations and investments within the Company's TRS during the period. National HealthCare Corporation ("NHC") Leased Portfolio Disposition

In April 2026, the Company executed a purchase and sale agreement with NHC/Op, L.P., a wholly owned subsidiary of NHC, and certain of its affiliates (collectively, the "NHC Purchaser") related to the sale of a portfolio of 35 properties in the Real Estate Investments segment that were leased to NHC. These properties consisted of 32 SNFs and three ILFs which were initially acquired by the Company in 1991. As of June 30, 2026, these properties were classified as assets held for sale and had an aggregate net carrying value of $13.6 million. The Company completed the sale of this portfolio on July 1, 2026 for cash consideration of  $560.0 million and expects to recognize a gain of approximately $541.6 million on the sale.

Contemporaneously with the closing of the sale of the NHC leased portfolio, the Company executed a partial master lease termination and partial assignment and assumption of the master lease agreement terminating the master lease agreement with NHC with respect to all properties, except four subleased properties located in Florida. The Company assigned to the NHC Purchaser, and the NHC Purchaser assumed from the Company, the master lease for the subleased properties. In July 2026, the Company recognized a reversal of deferred income of $0.5 million related to the lease termination as part of the gain on the sale of these properties.

Other Portfolio Activity

In April 2026, the Company amended the four master lease agreements with Bickford Senior Living ("Bickford") increasing the combined annual base rent for the portfolio of 37 properties to $38.4 million with annual rent escalators ranging between 2.0% and 3.0%. As a result of these amendments, Bickford is also required to pay contingent rent based on a percentage of the combined monthly revenues for all of the properties leased to Bickford that exceeds a base amount. In May 2026, the Company acquired a portfolio of seven senior housing properties located in Colorado with a combined total of 532 units. The total purchase price was $106.9 million, including closing costs. The properties were acquired pursuant to a Section 1031 reverse exchange transaction which was completed on July 1, 2026 when the NHC properties were sold. The properties are included in the SHOP segment and managed by Generations, LLC. In June 2026, the Company acquired two senior housing properties located in Georgia. The total purchase price was $17.5 million, including closing costs. The properties were acquired pursuant to a Section 1031 reverse exchange transaction which was completed on July 1, 2026 when the NHC properties were sold. The properties are included in the Real Estate Investments segment and leased pursuant to a triple-net lease with an initial annual lease rate of 8.0% and annual rent escalators of 2.0%. In the quarter ended June 30, 2026, the Company completed dispositions of four properties for aggregate net proceeds of $91.8 million. The aggregate net carrying amounts of these properties was $70.0 million.  The Company recognized an aggregate gain of $21.8 million on the sale of these properties. The Company received a $5.5 million mortgage note from an affiliate of the buyer related to one of these properties as part of the consideration. These properties were included in the Real Estate Investments segment. In addition to the sale of the NHC properties previously discussed, the Company completed the sale of two properties located in Texas for $19.0 million in cash consideration. These properties were included in the Real Estate Investments segment and classified as assets held for sale as of June 30, 2026. Recent Pipeline Developments

The Company currently has approximately $127.3 million of investment opportunities under signed Letters of Intent ("LOI") primarily in the SHOP segment with an average initial NOI yield of approximately 6.8%. The Company expects to utilize the proceeds from the Section 1031 exchange transaction initiated by the NHC portfolio sale for these opportunities. In addition to the signed LOIs, the Company is currently evaluating a pipeline of approximately $420 million of investments which include SHOP, sale-leasebacks and loans with purchase options primarily for senior housing properties. The pipeline excludes portfolio deals. Balance Sheet and Liquidity

As of June 30, 2026, the Company had $1.2 billion of consolidated net debt, including $438.0 million outstanding on its $700.0 million revolving credit facility. During the quarter ended June 30, 2026, the Company repaid the remaining $125.0 million outstanding on its bank term loan upon maturity.

The Company continues to maintain a strong financial profile with a consolidated net debt to adjusted EBITDA ratio of 4.1x, which is currently well within the Company's target range of 3.5x to 4.5x. The Company is in compliance with all debt covenants and has investment grade credit ratings from Moody's, S&P Global and Fitch Ratings.

ATM Equity Program

Concurrently with the renewal of its shelf registration statement in March 2026, the Company entered into a new equity distribution agreement whereby the Company can sell up to $500.0 million in common stock under its ATM equity program. During the quarter ended June 30, 2026, the Company settled the remaining $44.9 million of ATM forward equity sales agreements that were outstanding under the previous ATM equity program. As of June 30, 2026, the Company had $500.0 million available under its ATM equity program.

Dividend

On August 7, 2026, the Board of Directors declared an increase in the quarterly cash dividend to $0.94 per share from $0.92 per share. The dividend is payable on November 6, 2026 to common stockholders of record as of September 30, 2026.

2026 Full-Year Guidance

The Company's 2026 full-year guidance range, including information on the underlying assumptions and timing of certain transactions, is set forth below (in millions, except per share amounts):

2026 Guidance Range

Low

High

Net income attributable to common stockholders

$       703.0

$       705.2

Adjustments to NAREIT FFO:

Depreciation, net1

94.4

95.0

Gains on dispositions and impairments of real estate properties

(565.9)

(566.3)

Participating securities

0.8

1.0

NAREIT FFO attributable to common stockholders

232.3

234.9

Adjustments to Normalized FFO attributable to common stockholders:

Other





Normalized FFO attributable to common stockholders

232.3

234.9

Adjustments to FAD attributable to common stockholders:

Straight-line rent revenue and lease incentives amortization, net1

(0.1)

(0.3)

Equity method investment adjustments

(1.7)

(1.5)

Equity method investment non-refundable fees received

1.6

1.8

Non-cash share-based compensation expense

7.5

7.2

SHOP1 and equity method investment recurring capital expenditures

(4.0)

(3.8)

Other1,2

5.0

5.4

FAD attributable to common stockholders

$       240.6

$       243.7

Weighted average common shares outstanding - diluted

49.0

49.0

NAREIT FFO per diluted share

$        4.74

$        4.79

Normalized FFO per diluted share

$        4.74

$        4.79

1

Net of amounts attributable to noncontrolling interests

2

Includes credit loss reserves, non-real estate depreciation, net, amortizations associated with debt facilities and participating securities

The Company's 2026 full-year guidance includes the following assumptions:

$180 million in unidentified new investments; Approximately $665 million in expected proceeds from dispositions resulting in a gain ranging between $565.9 million - $566.3 million; Continued fulfillment of existing commitments; Same Store SHOP NOI growth on 15 properties ranging between 1% - 3% year over year; and Total SHOP NOI on 42 properties, before the assumption for unidentified new SHOP investments, ranging between $44.1 million - $45.1 million. In addition to the assumptions listed above, the Company's guidance range is based on several other assumptions, many of which are outside the Company's control and all of which are subject to change. The Company's guidance range may change if actual results vary from these assumptions.

Investor Conference Call and Webcast

The Company will host a conference call on Tuesday, August 11, 2026, at 8:30 a.m. ET, to discuss its second quarter 2026 results. The number to call for this interactive teleconference is (888) 506-0062, with the confirmation number 813991. The live broadcast of the Company's second quarter conference call will be available online at www.nhireit.com. The online replay will follow shortly after the call and remain available for one year.

About National Health Investors, Inc. 

National Health Investors, Inc. (NYSE: NHI), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust ("REIT"). The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing on senior housing communities and medical facilities. The Company operates through two reportable segments, Real Estate Investments and SHOP. The Company's real estate property investments include independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities and hospitals. For more information, visit www.nhireit.com.

Reconciliations of FFO, Normalized FFO and Normalized FAD

(unaudited and $ in thousands, except per share amounts)

Three Months Ended

Six Months Ended

June 30,

June 30,

2026

2025

2026

2025

Net income attributable to common stockholders

$        55,576

$        36,938

$        95,600

$        71,051

Real estate depreciation and amortization

24,583

19,477

47,415

38,241

Real estate depreciation attributable to noncontrolling interests

(404)

(414)

(806)

(827)

Gains on dispositions of real estate properties

(21,967)

(110)

(24,579)

(224)

Adjustments attributable to holders of participating securities

(4)



(24)



NAREIT FFO attributable to common stockholders

57,784

55,891

117,606

108,241

Proxy contest and related expenses



1,308



1,572

Normalized FFO attributable to common stockholders

57,784

57,199

117,606

109,813

Non-cash rent revenue adjustments, net

90

(459)

(58)

(1,283)

Non-real estate depreciation and amortization, net

888

377

1,673

715

Amortization of debt issuance costs and discounts

854

940

1,708

1,914

Adjustments attributable to equity method investment, net

(324)

(1,907)

(723)

(2,587)

Equity method investment non-refundable fees received

500

623

627

933

Recurring capital expenditures, net

(1,198)

(494)

(1,954)

(933)

Credit loss benefit

(59)

(1,393)

(109)

(1,407)

Share-based compensation expense

2,360

1,071

4,600

3,629

Deferred income tax expense

732



732



Transaction costs







1,164

Adjustments attributable to holders of participating securities

(7)



(11)



Normalized FAD attributable to common stockholders

$        61,620

$        55,957

$       124,091

$       111,958

Basic:

Weighted average common shares outstanding

48,435,914

46,691,953

48,379,930

46,206,225

NAREIT FFO attributable to common stockholders per share

$           1.19

$           1.20

$           2.43

$           2.34

Normalized FFO attributable to common stockholders per share

$           1.19

$           1.23

$           2.43

$           2.38

Diluted:

Weighted average common shares outstanding

48,498,181

46,822,465

48,523,038

46,350,498

NAREIT FFO attributable to common stockholders per share

$           1.19

$           1.19

$           2.42

$           2.34

Normalized FFO attributable to common stockholders per share

$           1.19

$           1.22

$           2.42

$           2.37

See the accompanying notes to the reconciliations of FFO, Normalized FFO, Normalized FAD and NOI.

The following table reconciles net income, the most directly comparable generally accepted accounting principles ("GAAP") financial

measure, to NOI (unaudited and $ in thousands):

Three Months Ended

Six Months Ended

June 30,

June 30,

2026

2025

2026

2025

Net income

$       55,357

$       36,689

$       95,109

$       70,506

Depreciation and amortization

25,548

19,918

49,239

39,075

Interest expense

15,814

15,001

30,854

29,338

Legal expense

445

1,095

750

2,521

Franchise, excise and other taxes

213

243

428

512

General and administrative expenses

8,823

6,125

16,674

12,954

Proxy contest and related expenses



1,308



1,572

Loan and realty gains, net

(59)

(1,393)

(109)

(1,407)

Gains on dispositions of real estate properties

(21,967)

(110)

(24,579)

(224)

Other non-operating income

(86)



(121)



Income tax expense

732



732



Gains from equity method investment



(1,524)



(1,939)

NOI

$       84,820

$       77,352

$      168,977

$      152,908

The following table provides a summary of the Company's NOI by segment (unaudited and $ in thousands):

Three Months Ended

Six Months Ended

June 30,

June 30,

2026

2025

2026

2025

Real Estate Investments segment

$       73,798

$       73,531

$      149,064

$      146,001

SHOP segment

11,022

3,821

19,913

6,907

Total NOI

$       84,820

$       77,352

$      168,977

$      152,908

The following table provides additional information on the Company's SHOP segment NOI (unaudited and $ in thousands):

Three Months Ended

Six Months Ended

June 30,

June 30,

2026

2025

2026

2025

Same Store properties1

$        3,582

$        3,821

$        6,594

$        6,907

Acquisitions

4,724



7,701



Transitioned properties

2,716



5,618



Total SHOP segment NOI

$       11,022

$        3,821

$       19,913

$        6,907

1

Same Store is defined in the notes below.

See the accompanying notes to the reconciliations of FFO, Normalized FFO, Normalized FAD and NOI.

Notes to the Reconciliations of FFO, Normalized FFO, Normalized FAD and NOI

The supplemental performance measures described below may not be comparable to similarly titled measures used by other REITs. Consequently, funds from operations ("FFO"), Normalized FFO, Normalized FAD and NOI, as presented herein, may not provide a meaningful measure of the Company's performance as compared to that of other REITs. Since other REITs may not use a similar definition of these performance measures, caution should be exercised when comparing FFO, Normalized FFO, Normalized FAD and NOI, as presented herein, to that of other REITs. These performance measures do not represent cash generated from operating activities in accordance with GAAP as they exclude the changes in operating assets and liabilities, and therefore should not be considered an alternative to net income as an indication of performance or as an alternative to net cash flows from operating activities, as determined in accordance with GAAP as a measure of liquidity, and are not necessarily indicative of cash available to fund cash needs.

Funds From Operations - FFO

FFO and Normalized FFO are important supplemental performance measures for REITs. These performance measures are useful in that the historical cost accounting convention under GAAP requires real estate assets, other than land, to be depreciated over their estimated useful lives implying that the realizable values of real estate assets diminish predictably over time. Since real estate asset values typically rise and fall with market conditions, presentations of operating results of REITs using the historical cost accounting convention could be considered less informative to investors and should be supplemented with a measure such as FFO. FFO was designed by the REIT industry as a supplemental performance measure to address this issue.

The Company defines FFO, or NAREIT FFO, as net income attributable to common stockholders excluding gains on dispositions of real estate properties, impairments of real estate properties and real estate depreciation and amortization expense. These exclusions are adjusted to remove the impact of amounts that are attributable to noncontrolling interests and holders of participating securities. The Company's computation of FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or have a different interpretation of the current NAREIT definition from that of the Company, and therefore caution should be exercised when comparing the Company's FFO to that of other REITs.

Normalized FFO excludes from FFO certain items which, due to their infrequent or unpredictable nature, may create some difficulty in comparing FFO for the current periods to similar prior periods. These adjustments may include, but are not limited to including, impairments of non-real estate assets, gains or losses on non-real estate assets and liabilities and recoveries of previous write-downs on mortgage and other notes receivable.

Funds Available for Distribution - FAD

Normalized FAD is also an important supplemental performance measure for REITs. It is a useful measure of liquidity and serves as an indicator of the Company's ability to distribute dividends to its stockholders each period. GAAP requires a lessor to recognize contractual lease payments as income on a straight-line basis over the expected term of the lease. This straight-line rent adjustment has the effect of reporting rental income that is significantly more or less than the contractual cash flows received pursuant to the terms of the lease agreements. GAAP also requires any discount or premium related to indebtedness and debt issuance costs to be amortized as non-cash adjustments to earnings. Normalized FAD includes adjustments for these types of non-cash items of a recurring nature typical to REITs and is further adjusted to reflect the cash outflows for recurring capital expenditures. Certain other costs that fluctuate that are not related to the recurring business are also excluded from Normalized FAD.

The Company defines Normalized FAD as Normalized FFO excluding straight-line rent revenue adjustments, amortization of lease incentives, non-real estate depreciation and amortization expense and amortization of debt issuance costs and discounts. The Company also adjusts Normalized FAD for the net change in its credit loss reserves, share-based compensation expense, SHOP capital expenditures, deferred income tax expense, as well as certain non-cash items related to the Company's equity method investment, such as straight-line lease expense and amortization of purchase accounting adjustments. The Company removes the impact of the above adjustments that are attributable to noncontrolling interests and holders of participating securities. Normalized FAD for the six months ended June 30, 2025 included an adjustment for transaction costs incurred related to a large transaction in the SHOP segment that did not materialize.

Net Operating Income - NOI

NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate assets. The Company defines NOI as total revenues, less tenant reimbursements of property operating expenses and senior housing operating expenses. The Company believes NOI provides investors relevant and useful information to investors as it measures the operating performance of real estate assets at the property level on an unleveraged basis. The Company uses NOI in making decisions on resource allocations to its operating segments.

Same Store

The Company defines Same Store as real estate properties owned, consolidated and operational for the full period in both comparative periods and that are not otherwise excluded; provided, however, that the Company may include selected properties that otherwise meet the Same Store criteria if they are included in substantially all of, but not a full, period for one or both of the comparative periods, and in management's judgment such inclusion provides a more meaningful presentation of the Company's segment performance.

Newly acquired properties, recently developed or redeveloped properties and properties undergoing an operator transition will be included in Same Store after five full quarters from the date of acquisition, transition or being placed into service. SHOP properties and properties with triple-net leases that have undergone operator or business model transitions will be included in Same Store once operating under consistent operating structures for the full period in both periods presented.

Properties are excluded from Same Store if they are: (i) sold, classified as assets held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (ii) impacted by significant disruptive events such as flood or fire; (iii) those properties that are currently undergoing a significant disruptive redevelopment; or (iv) those properties that are scheduled to undergo operator or business model transitions, or have transitioned operators or business models after the start of the prior comparison period.

Condensed Consolidated Statements of Income

(unaudited and $ in thousands, except per share amounts)

Three Months Ended

Six Months Ended

June 30,

June 30,

2026

2025

2026

2025

Revenues:

Rental income

$        71,390

$        70,270

$      144,540

$      139,136

Resident fees and services

44,779

14,217

81,839

28,156

Interest and other income

5,150

6,175

10,070

12,666

Total revenues

121,319

90,662

236,449

179,958

Expenses:

Depreciation and amortization

25,548

19,918

49,239

39,075

Interest expense

15,814

15,001

30,854

29,338

Senior housing operating expenses

33,757

10,396

61,926

21,249

Legal expense

445

1,095

750

2,521

Franchise, excise and other taxes

213

243

428

512

General and administrative expenses

8,823

6,125

16,674

12,954

Proxy contest and related expenses



1,308



1,572

Taxes and insurance on leased properties

2,742

2,914

5,546

5,801

Loan and realty gains, net

(59)

(1,393)

(109)

(1,407)

Total expenses

87,283

55,607

165,308

111,615

Gains on dispositions of real estate properties

21,967

110

24,579

224

Other non-operating income

86



121



Income before income taxes and equity

method investment

56,089

35,165

95,841

68,567

Income tax expense

(732)



(732)



Gains from equity method investment



1,524



1,939

Net income

55,357

36,689

95,109

70,506

Add: Net loss attributable to noncontrolling interests

314

298

664

646

Net income attributable to stockholders

55,671

36,987

95,773

71,152

Less: Net income allocated to participating securities

(95)

(49)

(173)

(101)

Net income attributable to common stockholders

$        55,576

$        36,938

$        95,600

$        71,051

Weighted average common shares outstanding:

Basic

48,435,914

46,691,953

48,379,930

46,206,225

Diluted

48,498,181

46,822,465

48,523,038

46,350,498

Earnings per share:

Basic

$           1.15

$           0.79

$           1.98

$           1.54

Diluted

$           1.15

$           0.79

$           1.97

$           1.53

Selected Condensed Consolidated Balance Sheet Data

($ in thousands)

June 30,

December 31,

2026

2025

(unaudited)

Real estate properties, net

$    2,566,472

$    2,472,272

Mortgage and other notes receivable, net

209,273

203,296

Cash and cash equivalents

30,388

19,624

Straight-line rents receivable

74,997

78,891

Assets held for sale, net

30,929

3,562

Other assets, net

52,143

19,242

Debt, net

1,274,522

1,163,814

National Health Investors, Inc. stockholders' equity

1,571,426

1,521,543

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company's expected future financial positions, results of operations, cash flows, funds from operations, dividend and dividend plans, financing opportunities and plans, capital market transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, acquisition integration, growth opportunities, expected rental income, continued qualification as a REIT, plans and objectives of management for future operations, continued performance improvements, ability to service and refinance debt obligations, ability to finance growth opportunities, and similar statements including, without limitation, those containing words such as "may", "will", "should", "believes", "anticipates", "expects", "intends", "estimates", "plans", "projects", "target", "likely" and other similar expressions are forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Such risks and uncertainties include those risks and uncertainties which are described under the heading "Risk Factors" in Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and the Company's the Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. Many of these factors are beyond the control of the Company and its management. The Company assumes no obligation to update any forward-looking statements, except as required by law, and these statements speak only as of the date on which they are made. Investors are urged to carefully review and consider the various disclosures made by the Company in its periodic reports filed with the Securities and Exchange Commission ("SEC"), including the risk factors and other information in the above referenced Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Copies of these filings are available at no cost on the SEC's website at https://www.sec.gov or on the Company's website at www.nhireit.com.

Contact: Todd M. Siefert, Chief Financial Officer
Phone: (615) 890-9100

SOURCE National Health Investors, Inc.